Absolutely, I often wonder the same. It’s certainly not the price action that’s keeping people from posting as anyone can see it has a spectacular chart. It’s successfully going into new territory to treat Cancer and Idiopathic Pulmonary Fibrosis and it’s been awarded two FDA approvals. It’s peers are in the 400m $us market cap .... AMP945 is proving to be more successful than its competitors. I see this as one hell of an opportunity ... .
(20min delay)